ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 890

$736K Total Retail Price of All Prescriptions

Rank: 126 out of 890

512 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 512 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

19% of this provider’s 512 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 13,154 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 420 390 1 1
LEVOTHYROXINE SODIUM 382 354 2 2
OMEPRAZOLE 382 352 2 8
HYDROCODONE-ACETAMINOPHEN 321 259 S3 4 3
CITALOPRAM HBR 292 282 5 20
SIMVASTATIN 287 270 6 5
FUROSEMIDE 242 235 7 7
ZOLPIDEM TARTRATE 241 220 8 19
HYDROCHLOROTHIAZIDE 239 197 9 9
ATORVASTATIN CALCIUM 237 223 10 13
TRAMADOL HCL 233 230 11 16
METFORMIN HCL ER 226 189 12 54
POTASSIUM CHLORIDE 225 222 13 11
LISINOPRIL 214 174 14 4
METOPROLOL TARTRATE 205 155 15 15
SERTRALINE HCL 200 198 16 26
GABAPENTIN 199 174 17 12
CYMBALTA 191 165 18 45
NAMENDA 188 175 19 36
NEXIUM 186 159 20 14
DIGOXIN 180 164 21 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 148 22 21
TAMSULOSIN HCL 167 159 23 32
CLOPIDOGREL 157 154 24 28
TRIAMTERENE-HCTZ 154 146 25 61
PRAVASTATIN SODIUM 147 108 26 10
AZITHROMYCIN 146 127 27 37
METOPROLOL SUCCINATE 146 128 27 17
ATENOLOL 141 137 29 23
DONEPEZIL HCL 136 124 30 30
BYSTOLIC 126 107 31 86
RANITIDINE HCL 122 99 32 49
SPIRONOLACTONE 119 115 33 85
WARFARIN SODIUM 117 111 34 24
NIFEDIPINE ER 114 114 35 75
ALLOPURINOL 114 94 35 31
PANTOPRAZOLE SODIUM 114 107 35 34
DIOVAN 113 113 38 33
DOXAZOSIN MESYLATE 106 103 39 70
LOVASTATIN 101 101 40 46
FLUTICASONE PROPIONATE 99 92 41 39
CARVEDILOL 97 88 42 22
CRESTOR 94 81 43 25
ESCITALOPRAM OXALATE 94 80 43 51
ZETIA 93 74 45 81
MELOXICAM 92 87 46 18
PLAVIX 89 80 47 42
SYNTHROID 87 87 48 53
LOSARTAN POTASSIUM 87 76 48 29
TRAZODONE HCL 86 85 50 40
METFORMIN HCL 85 73 51 6
AMITRIPTYLINE HCL 85 64 R 51 43
GLYBURIDE-METFORMIN HCL 84 77 R 53 115
PREDNISONE 84 82 53 47
ALENDRONATE SODIUM 83 83 55 38
VERAPAMIL ER 81 46 56 87
ACTOS 80 72 57 88
AMOXICILLIN 78 61 58 94
ETODOLAC 72 47 59 197
GLIPIZIDE XL 71 56 60 128
GLIPIZIDE 71 56 60 62
PROAIR HFA 70 60 62 55
LYRICA 69 63 63 71
POLYETHYLENE GLYCOL 3350 62 62 64 67
DIOVAN HCT 62 42 64 48
CEPHALEXIN 60 53 66 119
VENLAFAXINE HCL ER 60 60 66 114
CLONIDINE HCL 60 59 66 35
METOCLOPRAMIDE HCL 60 43 66 125
GLIPIZIDE ER 60 53 66 110
OLANZAPINE 59 42 71 145
CELEBREX 59 58 71 91
BUMETANIDE 57 53 73 134
PAROXETINE HCL 55 55 74 68
ENALAPRIL MALEATE 54 42 75 56
ISOSORBIDE MONONITRATE ER 54 54 75 60
LOSARTAN-HYDROCHLOROTHIAZIDE 54 42 75 57
AMOX TR-POTASSIUM CLAVULANATE 53 31 78 132
CLONAZEPAM 50 50 79 202
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.